Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

28.5K
Overview
28.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

431
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
431
Hypersensitivities01:30

Hypersensitivities

1.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.0K
Cross-reactivity00:42

Cross-reactivity

31.5K
Overview
31.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

560
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
560
Allergic Drug Reactions01:27

Allergic Drug Reactions

965
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
965

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sublingual immunotherapy tablets in monosensitized and polysensitized adults with allergic rhinoconjunctivitis.

Allergy and asthma proceedings·2023
Same author

Allergy immunotherapy for allergic fungal respiratory diseases.

Allergy and asthma proceedings·2023
Same author

The Art of Immunotherapy.

The journal of allergy and clinical immunology. In practice·2023
Same author

The Art of Dosing for Subcutaneous Immunotherapy in North America.

The journal of allergy and clinical immunology. In practice·2023
Same author

Allergy immunotherapy: Literature Review 2022.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2023
Same author

Extrapolating Evidence-Based Medicine of AIT Into Clinical Practice in the United States.

The journal of allergy and clinical immunology. In practice·2022
Same journal

Key factors in the diagnosis of sesame allergy in children.

Allergy and asthma proceedings·2026
Same journal

Immunoglobulin E-mediated pumpkin seed allergy in children: Case series and narrative review with a structured literature search.

Allergy and asthma proceedings·2026
Same journal

Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.

Allergy and asthma proceedings·2026
Same journal

The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites.

Allergy and asthma proceedings·2026
Same journal

The impact of dietary patterns on the risk of asthma in children.

Allergy and asthma proceedings·2026
Same journal

The alpha-gal syndrome: Understanding the role of tick bites, and the delays in severe anaphylaxis.

Allergy and asthma proceedings·2026
See all related articles

Related Experiment Video

Updated: Sep 5, 2025

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.6K

Future directions in allergen immunotherapy.

Harold S Nelson

    Allergy and Asthma Proceedings
    |July 12, 2022
    PubMed
    Summary
    This summary is machine-generated.

    Subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) effectively treat allergic rhinitis and asthma but face challenges. Emerging approaches like intralymphatic immunotherapy and vitamin D show promise for safer, shorter treatments.

    More Related Videos

    Antigenic Liposomes for Generation of Disease-specific Antibodies
    10:31

    Antigenic Liposomes for Generation of Disease-specific Antibodies

    Published on: October 25, 2018

    12.5K
    Intralymphatic Immunotherapy and Vaccination in Mice
    07:33

    Intralymphatic Immunotherapy and Vaccination in Mice

    Published on: February 2, 2014

    23.4K

    Related Experiment Videos

    Last Updated: Sep 5, 2025

    Humanized Mediator Release Assay as a Read-Out for Allergen Potency
    10:22

    Humanized Mediator Release Assay as a Read-Out for Allergen Potency

    Published on: June 29, 2021

    3.6K
    Antigenic Liposomes for Generation of Disease-specific Antibodies
    10:31

    Antigenic Liposomes for Generation of Disease-specific Antibodies

    Published on: October 25, 2018

    12.5K
    Intralymphatic Immunotherapy and Vaccination in Mice
    07:33

    Intralymphatic Immunotherapy and Vaccination in Mice

    Published on: February 2, 2014

    23.4K

    Area of Science:

    • Immunology
    • Allergy Research
    • Clinical Trials

    Background:

    • Subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are established treatments for allergic rhinitis and asthma.
    • These immunotherapies modify underlying immune responses but are limited by safety concerns, inconvenience, and long treatment durations (3-4 years).

    Purpose of the Study:

    • To review novel approaches aimed at improving the efficacy, safety, and duration of allergen immunotherapy.
    • To identify promising alternative immunotherapy strategies for allergic diseases.

    Main Methods:

    • Review of current and emerging allergen immunotherapy strategies.
    • Analysis of clinical trial outcomes and regulatory considerations for new approaches.

    Main Results:

    • Many innovative approaches have failed in larger trials.
    • Promising strategies include intralymphatic immunotherapy, epicutaneous immunotherapy, vitamin D supplementation for deficient patients, probiotics, and allergoids.
    • These require further research and regulatory approval.

    Conclusions:

    • Despite challenges with current SCIT and SLIT, ongoing research is exploring new methods to enhance allergen immunotherapy.
    • Intralymphatic immunotherapy, epicutaneous immunotherapy, vitamin D, probiotics, and allergoids represent potential future advancements, pending further validation.